CLINICAL_TRIALS
trial_result
· 2019-05-28
Clinical Trial Update: A Study to Compare the Safety and Efficacy of Romosozumab (AMG 785) Versus Placebo in Men With Osteoporosis [Phase 3]
Summary
Phase 3 study comparing Romosozumab to placebo in men with osteoporosis has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Amgen | Conditions: Osteoporosis in Men | Phase 3 | Status: COMPLETED | Results posted: 2019-05-28